This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on http://cancer.jmir.org/, as well as this copyright and license information must be included.
Cancer is a leading cause of death in the United States and across the globe. Cancer screening is an effective preventive measure that can reduce cancer incidence and mortality. While cancer screening is integral to cancer control and prevention, due to the COVID-19 outbreak many screenings have either been canceled or postponed, leaving a vast number of patients without access to recommended health care services. This disruption to cancer screening services may have a significant impact on patients, health care practitioners, and health systems. In this paper, we aim to offer a comprehensive view of the impact of COVID-19 on cancer screening. We present the challenges COVID-19 has exerted on patients, health care practitioners, and health systems as well as potential opportunities that could help address these challenges.
It is estimated that 606,520 Americans will die from cancer in 2020 [1], which is 4 times the number of recent projected deaths due to COVID-19 [2]. While cancer prevention and screening is integral to personal and population health, the cancer industry is experiencing seismic changes due to the COVID-19 outbreak [3,4]. Disruptions brought by COVID-19 have significantly interrupted almost all aspects of cancer control and prevention infrastructures, including canceled cancer screening services [3], deferred elective surgeries [5], dismantled therapeutic regimens [4], and furloughed health care practitioners [6].
One of the most severely impacted cancer control and prevention services is cancer screening. Cancer screening utilizes medical tests to identify precancerous lesions before cancer is formed or to detect cancer before it progresses into more advanced stages [7,8]. Screening is an effective prevention mechanism that could substantially reduce cancer incidence and mortality rates in patients [9-12]. While not curative, cancer screening has potential to decrease the burden of cancer [13]. Evidence shows that for women of all ages at average risk, screening is linked to an approximate 20% reduction in breast cancer mortality [14]. Data analysis further indicates that 3 times the deaths resulting from colorectal cancer would be avoided with one third of current costs if colorectal cancer screening rates in people aged 50-70 years improved to 80% [15]. For the genetically predisposed individual, the benefit of prescribed cancer screening has an even greater impact [16,17].
Cancer screening plays a critical role in early cancer detection, but COVID-19 has significantly hampered the cancer screening infrastructure [3]. To adjust the provision of health care resources, many cancer agencies have championed the idea of halting cancer screening services to patients [18-20]. After a US national emergency was declared on March 13, 2020, institutions such as the American Cancer Society have made the recommendation that people should pause their cancer screening plans during the COVID-19 outbreak until further notice [19]. This recommendation, along with other contextual factors (eg, social isolation measures), has caused drastic disruptions in cancer screening services. It is estimated that as a result of COVID-19, screenings for cancers of the breast, colon, and cervix have dropped by 94%, 86%, and 94% between January 20, 2020, and April 21, 2020, respectively [21]. Little is known about the impact the current pandemic will have on the cancer screening and prevention activities of patients, health care practitioners, and health systems. To bridge this gap, we aim to present the challenges COVID-19 has exerted on patients, health care practitioners, and health systems as well as potential opportunities that could help address these challenges.
Cancer Screening Challenges, Opportunities, and Solutions
Successful cancer screening is often carried out as a result of synergistic collaborations between patients, health care practitioners, and health systems [22-24]. Furthermore, as no evidence is available on the origin of the virus and no effective vaccine or curative medicine is available, both patients and health care practitioners also experience the shared unknowns and uncertainties regarding COVID-19. These uncertainties are also experienced by health systems, whose financial futures may be threatened. Therefore, to acknowledge the shared interests of patients, health care practitioners, and health systems in cancer screening, we organized evidence and insights around these key stakeholders to provide a connected and comprehensive understanding of the impact of COVID-19 on cancer screening (Figure 1).
Summary of challenges patients, health care professionals, and health systems face due to COVID-19.
Patients
Social determinants of health could be understood as the condition in which people are born, grow, live, work, and age [25]. In other words, as opposed to biological factors (eg, genetic traits), social determinants of health are a range of social, economic, political, and environmental factors that contribute to individuals’ health conditions and disparities, such as inequalities in cancer screening [26-28]. Results show that patients who have poor social determinants of health, such as lack of insurance, low income, and living in a deprived neighborhood, are often less likely to adopt cancer screening [28-30]. Evidence from randomized clinical trials further indicates that, compared to patients with private insurance, patients with Medicaid or with no insurance received reduced benefits from the same intervention program [31]. These combined insights may help explain why screenings for cancers have dropped significantly since January 2020 (eg, breast cancer screening has dropped by 94%) [21]. The experience of dramatic events, such as the COVID-19 pandemic, losing health insurance, and lack of access to health care, and in some situations caring for ill family members, may exert added psychological pressure on patients and further impact the ability to receive services and increase their risk of medical conditions such as cancer [32,33].
Another social determinant of health, economic stability, has been greatly affected. Due to the impact of COVID-19, unemployment rates rose to a historical 20.6% in the United States, with more than 31 million workers filing unemployment claims between March 1, 2020, and May 2, 2020 [34]. It is estimated that 26.6 million workers and their dependents may lose their employer-based insurance [35]. This undoubtedly can have a detrimental effect on individuals’ physical and psychological health, as health insurance status is often considered as a key social determinant of health that has substantial influence on individuals’ ability to access health care services [36,37].
Canceling or postponing cancer screenings may not equate to avoiding a cancer diagnosis but delayed cancer diagnoses could lead to increased mortality. On the contrary, the drastic decrease of cancer screenings in the United States and across the globe may have severe consequences, such as an unexpected rise in cancer incidence and later-stage cancer diagnosis, and in turn, more cancer deaths in patients [11,38-41]. While patients might be in great need for help during this crisis, assistance from health care practitioners was also interrupted due to the COVID-19 pandemic [42]. Furthermore, the accumulated need to screen those patients whose exams or procedures were postponed could directly impact other patients whose exams or procedures are now also due, creating downstream cancer screening delays.
Health Care Practitioners
One of the most impacted populations by COVID-19 is the health care practitioner community [43,44]. During the SARS (severe acute respiratory syndrome) outbreak, health care workers and hospital systems experienced measurable negative psychological impacts [45-48]. Due to the current outbreak, health care practitioners may have experienced a variety of multilevel stressors, such as (1) interruptions in routine job duties and responsibilities, (2) limited knowledge and data, and (3) worries about job security due to decreased patient volumes. COVID-19 has caused significant upheavals in the cancer health care infrastructure, including disturbed clinical visits, canceled or delayed medical surgery or procedures, and bridled therapeutic strategies [44,49]. For health care practitioners, these changes force them to tackle constant unexpected disruptions to routine job duties and responsibilities, such as the need to quickly learn and adopt telemedicine tools until COVID-19 ceases to be a threat to society. This unexpected need to adopt telemedicine may cause stress in health care practitioners, as some of them may be forced into adopting technology-based health solutions without necessary knowledge or adequate training in place [50]. These changes in job duties and responsibilities may put extra pressure on health care practitioners, above and beyond the levels of stress experienced by the general public in the face of COVID-19. For some health care practitioners, in addition to the unique work requirements and responsibilities they shoulder during the COVID-19 pandemic, the fear of being exposed to SARS-CoV-2 at work may cause additional stress and anxiety [43]. This, in turn, may cause detrimental consequences on their psychological health and their performance in administering cancer care and treatment to patients.
Without key information from insurance payers, health care practitioners may lack the necessary data needed to identify those who need cancer screening [27,51]. Though many health care practitioners have access to electronic health record systems, information stored in these systems is often too outdated and inaccurate to be utilized [51,52]. This suggests that limited data may also hamper health practitioners’ ability to help patients. Therefore, due to these issues coupled with COVID-19–related cancer screening cancelations and delays [21], health care professionals’ performance in value-based contracts are at risk [53]. One consequence could be decreased screening rates and the resulting poor performance in cancer screening metrics, which in turn can lead to decreased quality incentives [54,55].
Reduced successful cancer care could be manifested in terms of decreased profits and diminished research funding [53], which may then result in downstream cost reduction and job loss. As a matter of fact, health care institutions, including hospitals and nonprofit organizations, such as the American Cancer Society, have been downsizing in the form of furloughs and layoffs [6]. According to the Labor Department, 1.4 million health care practitioners have lost their job since January 2020 [56]. This grim job reality could exert additional pressure to the unknowns and uncertainties health care practitioners are facing while trying to protect themselves and patients from COVID-19.
Health Systems
In the context of cancer screening, the impact of COVID-19 on health systems can be best illustrated in terms of loss: (1) loss of lives, (2) loss of talent, and (3) loss of operational activity and revenues. Globally, it is estimated that 2,324,069 elective cancer surgeries (37.7% of all 1,735,483 elective surgical operations) were canceled or postponed during the 12-week peak disruptions caused by COVID-19 [5]. These cancelations and delays could cause cancer disparities to become more pronounced. It is difficult to know how these discontinued services could further negatively impact the patient-provider relationship.
It is also hard to predict how patients will respond to cancer screening messages from health care practitioners post COVID-19. Public perception of health care safety could impact utilization patterns of health care [57-59]. Since COVID-19 is seen as highly infectious and can be contracted from direct contact with others [60,61], it is possible that the current avoidance of health care may continue and patients without symptoms may opt to not be screened for preventive care. This could have a detrimental effect on patients’ health, as many chronic medical condition such as cancer, high blood pressure, and diabetes are often asymptomatic until needing urgent attention [62-64]. Furthermore, drastic changes in patients’ social determinants of health (eg, health insurance status, geographic distance from health care center and associated transportation needs, etc) may also contribute to the development of other non–cancer-related illnesses [65-68], resulting in competing interests in health care decisions that could further dampen patients’ motivation to seek cancer screening services [69]. This, in turn, may also contribute to an increase of later-stage cancer diagnosis in patients. Early data from the United Kingdom predicts a substantial increase in the number of avoidable cancer-related deaths in England [70]. Other estimates predict COVID-19 will result in 10,000 excess deaths from breast and colorectal cancer [71].
Health care practitioners are losing their jobs, partially due to the dwindled demands for health care services caused by COVID-19. Overall, 1.4 million health care practitioners lost their jobs since January 2020 [56]. Though the potential impact of COVID-19 on medical and nursing school enrollments is yet to be ascertained, it is possible that COVID-19 may have a negative impact on health care practitioners’ ability to provide high-quality education. Moreover, the impact of reduced patient contact and virtual learning on educational milestone attainment are yet to be determined.
While it is difficult to pinpoint the exact impact of disrupted cancer screening services on the loss of life or loss of talent in the health care industry, it is easier to describe the decreased activity and estimated the loss of profits in the health care industry caused by COVID-19. According to the American Hospital Association, due to the impact of this coronavirus, the estimated loss of US hospitals and health systems between February 2020 and June 2020 would amount to $202.6 billion [53]. This loss of profit may also have an impact on patients and health care practitioners, considering that loss of profits often translate into reduced investments in cancer research [6]. However, while these numbers present a dismal reality, opportunities and solutions that could address the challenges caused by COVID-19 on cancer screening are also available.
The impact of these health system issues on cancer screening measures are coming to light, especially as it relates to cancer screening. The World Health Organization warned of a worldwide decrease in health services for noncommunicable diseases [72]. These results include predicted increases in avoidable cancer deaths [70]. Many health care systems are finding fewer cancer diagnoses during the pandemic [73,74]. Fewer diagnoses can have financial impact on health care systems, especially when the United States spent roughly $87.8 billion on cancer-related health care in 2014 [75].
Cancer Screening for At-Risk Patient Populations
We also need to pay attention to where the COVID-19 pandemic hit hardest and where cancer screening rates are the lowest in our community [76-85]. Patients with low socioeconomic status (SES) or identify as minority, including racial and ethnic underserved minorities such as Hispanics and African Americans, and the LGBTQ (lesbian, gay, bisexual, transgender, and queer or questioning) sexual and gender minorities. It is important to recognize that there is a huge overlap between patients with low SES and those with minority status—rather than face the double impact of being poor and disenfranchised (eg, heightened risks for cancer) [84,86-88], as a result of COVID-19, they now face the additional impact of the need to pay extra attention and allocate already limited resources to protect themselves against the coronavirus while also tackling unemployment or hazardous working conditions [89-91].
It is important to note that the impact of missing a cancer screening is not the same for every population [92,93]. Evidence suggests that marginalized individuals such as racial minorities are more likely to benefit from cancer screening [94]. Research also indicates that cancer screening is more cost-effective for high-risk races and ethnicities, such as Asians ($71,451 per quality-adjusted life year [QALY]), Hispanics ($76,070/QALY), African Americans ($80,278/QALY), compared to non-Hispanic White individuals ($122,428/QALY) [95]. While these findings further support the importance of cancer screening, they also indicate that the likelihood of missing a diagnosis by delayed or missed screening will be amplified among these minority populations. In other words, screening is integral to these populations’ protection against cancer.
COVID-19 has also helped expose many health disparities minorities face, especially structured and systematic health inequalities such as violence against women [77,96-99]. Prior to COVID-19, data from the World Health Organization already painted a horrifying picture where 1 in 3 women will become a victim of sexual or physical violence in a relationship at some point in their life [100]. A growing body of literature suggests that, as the pandemic and lockdown measures bring continuing financial blows and forced “close” time with their partners, women worldwide are experiencing more frequent and dangerous forms of abuse [77,96,98].
With so many people taking a stand and making their voice heard over injustice, as exemplified by the belated realization of police brutality in the United States, there is a societal need to pay attention to the disparities and inequalities that, we, as a population, are experiencing on a daily basis. “Pay inequity” [101] or “violence against women” [77,100] are more than inhumane terminologies or irrelevant phenomena to leave as inheritance for future generations—rather, these disparities are negatively impacting our grandmothers, mothers, and daughters’ well-being and making them less likely to screen for cancer [102,103] and thus more at risk for missing early cancer detection [104-106]. It is questionable as to how likely a woman experiencing domestic violence will undertake the initiative to screen for breast cancer amid the pandemic, even if she is aware that lumps in her breasts have appeared or changed. The ramifications of COVID-19 are thus profound.
More attention from health care practitioners are required to address these issues while improving screening rates for the highest at-risk populations. In other words, these health disparities that minorities face are meaningful and life-or-death facts that health care practitioners must acknowledge and address.
Some of the approaches to more universal access to cancer screening using traditional and organized outreach measures include local mammography vans for breast cancer [38,107], fecal immunochemical test (FIT) or other at-home stool tests for colon cancer detection [108,109], and cost-effective technology-based solutions such as social media campaigns [110,111], so that a broader population can be served and the widening cancer disparities can be alleviated. In the fight against inequalities, preventative measures such as cancer screening are more relevant to underserved populations than ever before. Since COVID-19 is more likely to be deadly for marginalized individuals with chronic conditions and cancer [112-116], it is important to ensure people can fight to overcome social determinants and injustices with maintaining a healthy and cancer-free body.
Opportunities and SolutionsTelemedicine Opportunities and Technology-Based Solutions
With the advances in science and technology, the application of telemedicine in cancer care and management is gaining momentum [117-119]. Telemedicine, which literally means “healing at a distance” [120], could be understood as the delivery of health care services aiming to advance personal and population health [121]. Telemedicine allows timely, accessible, and cost-effective health care delivery to the patients, which renders itself a practical solution to COVID-19–induced constraints such as social distancing and self-isolation [122-124]. Telemedicine tools such as virtual reality devices have been found to be useful for training health care practitioners [125]. As virtual reality can offer remote yet realistic training experiences, it facilitates training for health care professionals in a time when social isolation is the norm. Telemedicine has been shown to be effective in underserved geographically remote populations. Emerging technologies such as artificial intelligence (AI) also have great potential in facilitating cancer screening [119].
On a higher-technological scale, using a deep learning technique, researchers found that AI can help identify faces of patients with cancer from those without [126]. This promising finding, not currently in use, suggests that AI-based telemedicine tools have the future potential to assist patients and health care practitioners with cancer screening and improve screening accuracy.
While promising telemedicine opportunities are present, to successfully implement telemedicine in cancer care and primary care, education and training should be made available to both patients and health care practitioners [118]. Research conducted by Stanford University shows that 47% of physicians and 73% of medical students surveyed indicated that they are considering taking additional courses to better prepare for innovations in health care (eg, data science, AI) [127]. While it is imperative to update college curricula to reflect health care needs identified in practice [128,129], it is important to note that telemedicine education and training should be considered as a long-term investment, rather than a short-term experiment. In other words, as technology advances, telemedicine education and training programs should also be updated regularly and frequently to ensure health care practitioners are up to date with telemedicine opportunities for the benefits of self and patients [130,131].
According to the Pew Research Center, approximately 96% of Americans own a cellphone of some kind [132]. Considering the prevalence of smart devices patients own, health care practitioners may face questions like “Which mobile apps can help me better take care of my health?” from patients more frequently in the future. There is also a boom in the medical app market. It was estimated that there were approximately 325,000 health apps available to patients in 2017, equating to 3.7 billion app downloads in total [133]. As mobile health (mHealth) continues to gather momentum, health care practitioners may also need to “prescribe” mobile apps to patients to protect them from ill-suited (eg, apps addressing different sets of needs) or poorly developed apps (eg, apps filled with misinformation or lack of scientific underpinning) [134]. Technology competence might be an integral part to effective patient-provider communication [123]. To embrace future technology-based health care challenges, health care practitioners may have to train their telemedicine muscles with regular education to be able to adequately answer patients’ questions and concerns about telemedicine.
Leveraging Social Media to Boost Cancer Screening
In addition to boosting health care professionals’ core competence with regard to telemedicine [131], health systems should also consider adopting integrated marketing campaigns, such as social media campaigns, to increase screening awareness and adoption rates in patients. Social media campaigns could be understood as the use of social media platforms to deliver persuasive communication strategies to the target audience in order to change their attitudes and behavior to improve health. One key advantage of social media campaigns is that as persuasive strategies adopted in these campaigns are evidence-based and tailored to the target audience [135,136], they often yield desirable campaign outcomes [137-139].
Social media campaigns may be extremely useful for promoting cancer screening services to at-risk populations. Compared to integrated marketing campaigns distributed via traditional media platforms, social media campaigns can be distributed remotely with limited costs and therefore have the added advantages of cost-effectiveness and scalability [135,136]. This advantage might be more pronounced in the era of COVID-19; since lockdowns and social distancing measures have limited people’s ability to physically disseminate campaign messages, campaign mechanisms that can virtually distribute promotional information are desired. Evidence suggests that social media campaigns are effective in raising cancer screening awareness in the target audience [110,111,140]. Promising findings show that social media campaigns on lung cancer screening using Google and Facebook to reach at-risk populations yielded click-through rates above the industry standard [110]. These insights suggest that health care professionals can consider using social media campaigns to reach at-risk populations, such as minorities with pronounced needs to be screened for cancer, to further address the widening cancer disparities exacerbated by COVID-19.
Conclusion
The systemic disruption and tragedy that COVID-19 has brought to patients, practitioners, and health care systems is an opportunity for innovative solutions, especially in cancer prevention and screening [141-143]. Cancer prevention and screening professionals need to innovate in this current environment to continue to decrease the burden of cancer in communities. We need agile short-term plans tailored to the current COVID-19 infection control strategies as well as long-term plans that account for the capricious, costly, and deadly nature of cancer and its intersection with other widespread health problems, such as viral infections similar to the current pandemic. We offer some post–COVID-19 screening enhancement recommendations below:
Breast cancer screening
Mobile mammography unit
Cervical cancer screening
Pap smears +/– cotesting per guidelines
Colon cancer screening
Enhanced workflows for FIT or Cologuard with appropriate patients
General solutions:
Proactive outreach to patients due for screening
Social media communication to patients about risks of cancer and safety of screening procedures
Initial assessment and results follow-up via telemedicine appointment
Masking precautions (patient, clinician, and staff)
Social distancing precautions when possible
Complacency is not an option, and health care professionals must diligently work together with other stakeholders and across disciplines toward solutions to ensure patients, providers, and health systems have the tools and means necessary to screen for cancer now.
AbbreviationsAI
artificial intelligence
FIT
fecal immunochemical test
LGBTQ
lesbian, gay, bisexual, transgender, and queer or questioning
mHealth
mobile health
QALY
quality-adjusted life year
SARS
severe acute respiratory syndrome
SES
socioeconomic status
We thank Dr Pam Otto, Dr Randy Wright, Dr Georgia McCann, and the Cancer Prevention and Screening Committee of UT Health San Antonio Mays Cancer Center for informing our work. This work is supported by the Mays Cancer Center (support grant NIH 5P30CA054174) and the Cancer Prevention and Research Institute (PP120089 and PP160011).
RM is a consultant for Novartis, Sierra Oncology, and LaJolla Pharmaceutical and provides research support to Celgene, Incyte, AbbVie Inc, Samus Therapeutics, Genetech, Promedior, and CTI biopharma.
SiegelRMillerKJemalACancer statistics, 2020CA Cancer J Clin20200170173010.3322/caac.2159031912902COVID-19 forecastsCenters for Disease Control and Prevention20202020-09-01https://www.cdc.gov/coronavirus/2019-ncov/covid-data/forecasting-us.htmlWaterhouseDMHarveyRDHurleyPLevitLAKimESKlepinHDMilehamKFNowakowskiGSchenkelCDavisCBruinoogeSSSchilskyRLEarly Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology SurveyJCO Oncology Practice20200716741742110.1200/op.20.00275RenXChenBHongYLiuWJiangQYangJQianQJiangCThe challenges in colorectal cancer management during COVID-19 epidemicAnn Transl Med2020048749849810.21037/atm.2020.03.15832395542atm-08-07-498PMC7210180CovidSurg CollaborativeElective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plansBr J Surg20200613107111440144910.1002/bjs.11746American Association for Cancer ResearchCOVID-19 Hits Cancer Research FundingCancer Discov2020042410675675610.1158/2159-8290.cd-nd2020-007Cancer: ScreeningWorld Health Organization2020-09-01https://www.who.int/cancer/prevention/diagnosis-screening/screening/en/Division of Cancer Prevention and ControlScreening testsCenters for Disease Control and Prevention20202020-09-01https://www.cdc.gov/cancer/dcpc/prevention/screening.htmLiebermanDSullivanBAHauserERQinXMusselwhiteLWO'LearyMeghan CReddingTSMadisonANBullardAJThomasRSimsKJWilliamsCDHyslopTWeissDGuptaSGelladZFRobertsonDJProvenzaleDBaseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy SurveillanceGastroenterology2020031584862874.e810.1053/j.gastro.2019.07.05231376388S0016-5085(19)41149-9RanTChengCMisselwitzBBrennerHUbelsJSchlanderMCost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic ReviewClin Gastroenterol Hepatol201909171019691981.e1510.1016/j.cgh.2019.01.01430659991S1542-3565(19)30034-5MillerEAPinskyPFSchoenREProrokPCChurchTREffect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial2019024210111010.1016/s2468-1253(18)30358-3HallowellBDEndeshawMMcKennaMTSenkomagoVRazzaghiHSaraiyaMCervical Cancer Death Rates Among U.S.- and Foreign-Born Women: U.S., 2005-2014Am J Prev Med20190656686987410.1016/j.amepre.2019.01.00731005467S0749-3797(19)30040-6PMC6527456Institute of Medicine (US) and National Research Council (US) National Cancer Policy BoardCurrySusan JByersTHewittMFulfilling the Potential of Cancer Prevention and Early Detection2003Washington DCNational Academies Press (US)MyersERMoormanPGierischJMHavrileskyLJGrimmLJGhateSDavidsonBMongtomeryRCCrowleyMJMcCroryDCKendrickASandersGDBenefits and Harms of Breast Cancer Screening: A Systematic ReviewJAMA201510203141516153410.1001/jama.2015.13183265015372463261LadabaumUMannalitharaAMeesterRGGuptaSSchoenRECost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 YearsGastroenterology201907157113714810.1053/j.gastro.2019.03.02330930021S0016-5085(19)33578-4PMC7161092GuptaSProvenzaleDRegenbogenSEHampelHSlavinTPHallMJLlorXChungDCAhnenDJBrayTCooperGEarlyDSFordJMGiardielloFMGradyWHalversonALHamiltonSRKlapmanJBLarsonDWLazenbyAJLynchPMMarkowitzAJMayerRJNessRMSamadderNJShikeMSugandhaSWeissJMDwyerMAOgbaNNCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017J Natl Compr Canc Netw2017120915121465147510.6004/jnccn.2017.017629223984jnccn_15_12_009DalyMPilarskiRYurgelunMBerryMichael PBuysSaundra SDicksonPatriciaDomchekSusan MElkhananyAhmedFriedmanSusanGarberJudy EGogginsMichaelHuttonMollie LKhanSeemaKleinCatherineKohlmannWendyKurianAllison WLarongaChristineLittonJennifer KMakJulie SMenendezCarolyn SMerajverSofia DNorquistBarbara SOffitKennethPalTuyaPedersonHolly JReiserGwenShannonKristen MahoneyVisvanathanKalaWeitzelJeffrey NWickMyra JWisinskiKari BDwyerMary ADarlowSusan DNCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020J Natl Compr Canc Netw20200418438039110.6004/jnccn.2020.001732259785jnccnGLINS1804ASBrS and ACR joint statement on breast screening exams during the COVID-19 pandemicThe American Society of Breast Surgeons20203262020-09-01https://www.breastsurgeons.org/news/?id=45FalcoMCommon questions about the new coronavirus outbreakAmerican Cancer Society202010122020-10-19https://www.cancer.org/latest-news/common-questions-about-the-new-coronavirus-outbreak.htmlASCCP interim guidance for timing of diagnostic and treatment procedures for patients with abnormal cervical screening testAmerican Society for Colposcopy and Cervical Pathology20203192020-09-01https://www.asccp.org/covid-19Preventive cancer screenings during COVID-19 pandemicEpic Health Research Network20202020-09-01https://ehrn.org/articles/delays-in-preventive-cancer-screenings-during-covid-19-pandemicWarnerETLathanCSRace and sex differences in patient provider communication and awareness of lung cancer screening in the health information National Trends Survey, 2013-2017Prev Med201907124849010.1016/j.ypmed.2019.05.00131054908S0091-7435(19)30167-7WilliamsonSPattersonJCrosbyRJohnsonRSandhuHJohnsonSJenkinsJCaseyMKearinsOTaylor-PhillipsSCommunication of cancer screening results by letter, telephone or in person: A mixed methods systematic review of the effect on attendee anxiety, understanding and preferencesPrev Med Rep2019031318919510.1016/j.pmedr.2018.12.01630666286S2211-3355(18)30288-2PMC6330510SavaMGDolanJGMayJHVargasLGA personalized approach of patient-health care provider communication regarding colorectal cancer screening optionsMed Decis Making2018040338560161310.1177/0272989x18763802Social determinants of healthWorld Health Organization2020-09-01https://www.who.int/social_determinants/en/MosqueraIMendizabalNMartínUnaiBacigalupeAmaiaAldasoroElenaPortilloIsabelfrom the Desberdinak GroupInequalities in participation in colorectal cancer screening programmes: a systematic reviewEur J Public Health2020060130341642510.1093/eurpub/ckz236323617325828321AbdelsattarZMHendrenSWongSLThe impact of health insurance on cancer care in disadvantaged communitiesCancer2017040112371219122710.1002/cncr.3043127859019PMC5360496LoftersASchulerASlaterMBaxterNPersaudNPintoAKucharskiEDavieSNisenbaumRKiranTUsing self-reported data on the social determinants of health in primary care to identify cancer screening disparities: opportunities and challengesBMC Fam Pract201702281813110.1186/s12875-017-0599-z2824178710.1186/s12875-017-0599-zPMC5330155KuraniSSMcCoyRGLampmanMADoubeniCAFinney RuttenLJInselmanJWGiblonREBunkersKSStroebelRJRushlowDChawlaSSShahNDAssociation of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US MidwestJAMA Netw Open2020030233e20061810.1001/jamanetworkopen.2020.0618321502712762392PMC7063513CoughlinSSSocial determinants of colorectal cancer risk, stage, and survival: a systematic reviewInt J Colorectal Dis2020062135698599510.1007/s00384-020-03585-z3231419210.1007/s00384-020-03585-zUngerJMBlankeCDLeBlancMBarlowWEVaidyaRRamseySDHershmanDLAssociation of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive FindingsJAMA Netw Open2020040134e20384210.1001/jamanetworkopen.2020.3842323525302765202PMC7193331ManRXLackDAWyattCEMurrayVThe effect of natural disasters on cancer care: a systematic reviewThe Lancet Oncology201809199e482e49910.1016/s1470-2045(18)30412-1ProhaskaTPetersKImpact of Natural Disasters on Health Outcomes and Cancer Among Older AdultsGerontologist2019051759Suppl 1S50S5610.1093/geront/gnz018311001415491125Unemployment insurance weekly claimsUS Department of Labor20202020-09-01https://oui.doleta.gov/unemploy/claims.aspGarfieldRClaxtonGDamicoALevittLEligibility for ACA health coverage following job lossKaiser Family Foundation20205132020-09-01https://www.kff.org/coronavirus-covid-19/issue-brief/eligibility-for-aca-health-coverage-following-job-loss/SmithMAWeissJMPotvienASchumacherJRGangnonREKimDHWeeth-FeinsteinLAPickhardtPJInsurance Coverage for CT Colonography Screening: Impact on Overall Colorectal Cancer Screening RatesRadiology201709284371772410.1148/radiol.201717092428696184PMC5584666MossJLMurphyJFiliaciVLWenzelLBMinasianLTemkinSMDisparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinantsSupport Care Cancer2019021227253153810.1007/s00520-018-4340-93000334110.1007/s00520-018-4340-9PMC6330149VangSMargoliesLRJandorfLMobile Mammography Participation Among Medically Underserved Women: A Systematic ReviewPrev Chronic Dis2018111515E14010.5888/pcd15.18029130447104E140PMC6266518TarverWLHaggstromDAThe Use of Cancer-Specific Patient-Centered Technologies Among Underserved Populations in the United States: Systematic ReviewJ Med Internet Res20190423214e1025610.2196/1025631012855v21i4e10256PMC6658273HoughtonLCHowlandREMcDonaldJAMobilizing Breast Cancer Prevention Research Through Smartphone Apps: A Systematic Review of the LiteratureFront Public Health2019116729810.3389/fpubh.2019.0029831781525PMC6851054UyCLopezJTrinh-ShevrinCKwonSShermanSLiangPText Messaging Interventions on Cancer Screening Rates: A Systematic ReviewJ Med Internet Res20170824198e29610.2196/jmir.789328838885v19i8e296PMC5590008RomeoACastelliLFrancoPThe Effect of COVID-19 on Radiation Oncology Professionals and Patients With Cancer: From Trauma to Psychological GrowthAdv Radiat Oncol2020075470570610.1016/j.adro.2020.04.02432395671S2452-1094(20)30118-4PMC7211720ShanafeltTRippJTrockelMUnderstanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 PandemicJAMA20200602323212133213410.1001/jama.2020.5893322591932764380DesideriIPilleronSBattistiNMLGomesFde GlasNNeuendorffNRLipositsGParedero-PérezIreneLokWCWLohKPDuMontierCMianHSoto-Perez-de-CelisECaring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspectiveJ Geriatr Oncol2020091171175118110.1016/j.jgo.2020.05.00132402764S1879-4068(20)30215-0PMC7252080MaunderRLanceeWBaldersonKBennettJBorgundvaagBEvansSFernandesCGoldbloomDGuptaMHunterJMcGillis HallLNagleLPainCPeczeniukSRaymondGReadNRourkeSSteinbergRStewartTVanDeVelde-CokeSVeldhorstGWasylenkiDLong-term psychological and occupational effects of providing hospital healthcare during SARS outbreakEmerg Infect Dis200612121219243210.3201/eid1212.06058417326946PMC3291360MaunderRHunterJVincentLBennettJPeladeauNLeszczMSadavoyJVerhaegheLMSteinbergRMazzulliTThe immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospitalCMAJ200305131681012455112743065PMC154178GraceSLHershenfieldKRobertsonEStewartDEThe occupational and psychosocial impact of SARS on academic physicians in three affected hospitalsPsychosomatics2005094653859110.1176/appi.psy.46.5.38516145182S0033-3182(05)70049-9PMC7118753ChuDChenRKuCChouPThe impact of SARS on hospital performanceBMC Health Serv Res200811068122810.1186/1472-6963-8-228189902101472-6963-8-228PMC2613902SegelovEUnderhillCPrenenHKarapetisCJacksonCNottLClayTPavlakisNSabesanSHeywoodESteerCLethborgCGanHKYipDKaranthNKarikiosDMacIntyreCRPractical Considerations for Treating Patients With Cancer in the COVID-19 PandemicJCO Oncology Practice20200816846748210.1200/op.20.00229MetiNRossosPGCheungMCSinghSVirtual Cancer Care During and Beyond the COVID-19 Pandemic: We Need to Get It RightJCO Oncology Practice20200916952752910.1200/op.20.00281ColeAMPflugeisenBSchwartzMRMillerSCCross sectional study to assess the accuracy of electronic health record data to identify patients in need of lung cancer screeningBMC Res Notes201801101111410.1186/s13104-018-3124-02932103810.1186/s13104-018-3124-0PMC5763525MarinoMAngierHValenzuelaSHoopesMKillerbyMBlackburnBHuguetNHeintzmanJHatchBO'MalleyJPDeVoeJEMedicaid coverage accuracy in electronic health recordsPrev Med Rep2018091129730410.1016/j.pmedr.2018.07.00930116701S2211-3355(18)30122-0PMC6082971Hospitals and health systems face unprecedented financial pressures due to COVID-19American Hospital Association202052020-09-01https://www.aha.org/guidesreports/2020-05-05-hospitals-and-health-systems-face-unprecedented-financial-pressures-duePetersenLAWoodardLDUrechTDawCSookananSDoes pay-for-performance improve the quality of health care?Ann Intern Med2006081514542657210.7326/0003-4819-145-4-200608150-0000616908917145/4/265GreenEPetersonKSMarkiewiczKO'BrienJArringNMCautionary study on the effects of pay for performance on quality of care: a pilot randomised controlled trial using standardised patientsBMJ Qual Saf2020080629866467110.1136/bmjqs-2019-01026031907323bmjqs-2019-010260The employment situation—September 2020US Bureau of Labor Statistics20201022020-10-19https://www.bls.gov/news.release/pdf/empsit.pdfBednarczykRAChuSLSicklerHShawJNadeauJAMcNuttLLow uptake of influenza vaccine among university students: Evaluating predictors beyond cost and safety concernsVaccine2015033033141659166310.1016/j.vaccine.2015.02.03325728320S0264-410X(15)00222-4CronholmPFBowmanMAWomen with safety concerns report fewer gender-specific preventive healthcare servicesJ Womens Health (Larchmt)2009071871011810.1089/jwh.2008.096819563248AkbarSCoieraEMagrabiFSafety concerns with consumer-facing mobile health applications and their consequences: a scoping reviewJ Am Med Inform Assoc2020020127233034010.1093/jamia/ocz175315999365585394PMC7025360SunPLuXXuCSunWPanBUnderstanding of COVID-19 based on current evidenceJ Med Virol2020060592654855110.1002/jmv.2572232096567PMC7228250DowdJBAndrianoLBrazelDMRotondiVBlockPDingXLiuYMillsMCDemographic science aids in understanding the spread and fatality rates of COVID-19Proc Natl Acad Sci U S A20200505117189696969810.1073/pnas.2004911117323000182004911117PMC7211934MuggahEGravesEBennettCManuelDGAscertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-reportBMC Public Health201301091311610.1186/1471-2458-13-16233022581471-2458-13-16PMC3557162BeagleholeREpping-JordanJPatelVChopraMEbrahimSKiddMHainesAImproving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health careThe Lancet200809372964294094910.1016/s0140-6736(08)61404-xWendimagegnNFBezuidenhoutMThe integrated health service model: the approach to restrain the vicious cycle to chronic diseasesBMC Health Serv Res2019053119134710.1186/s12913-019-4179-x3115145110.1186/s12913-019-4179-xPMC6544908NomuraSParsonsAJHirabayashiMKinoshitaRLiaoYHodgsonSSocial determinants of mid- to long-term disaster impacts on health: A systematic reviewInternational Journal of Disaster Risk Reduction20160616536710.1016/j.ijdrr.2016.01.013Prüss-UstünAWolfJCorvalánCNevilleTBosRNeiraMDiseases due to unhealthy environments: an updated estimate of the global burden of disease attributable to environmental determinants of healthJ Public Health (Oxf)2017090139346447510.1093/pubmed/fdw08527621336fdw085PMC5939845RuckertALabontéRonaldHealth inequities in the age of austerity: The need for social protection policiesSoc Sci Med20170818730631110.1016/j.socscimed.2017.03.02928359581S0277-9536(17)30175-2CockerhamWCHambyBWOatesGRThe Social Determinants of Chronic DiseaseAm J Prev Med201701521S1S5S1210.1016/j.amepre.2016.09.01027989293S0749-3797(16)30440-8PMC5328595RoslandAKiefferECTipirneniRKullgrenJTKirchMArntsonEKClarkSJLeeSSolwayEBeathardEAyanianJZGooldSDDiagnosis and Care of Chronic Health Conditions Among Medicaid Expansion Enrollees: a Mixed-Methods Observational StudyJ Gen Intern Med2019111134112549255810.1007/s11606-019-05323-w3151218410.1007/s11606-019-05323-wPMC6848397MaringeCSpicerJMorrisMPurushothamANolteESullivanRRachetBAggarwalAThe impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling studyThe Lancet Oncology2020082181023103410.1016/s1470-2045(20)30388-0SharplessNECOVID-19 and cancerScience2020061936864971290129010.1126/science.abd337732554570368/6497/1290COVID-19 significantly impacts health services for noncommunicable diseasesWorld Health Organization2020612020-09-01https://www.who.int/news-room/detail/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseasesKaufmanHWChenZNilesJFeskoYChanges in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) PandemicJAMA Netw Open2020080338e201726710.1001/jamanetworkopen.2020.17267327494652768946PMC7403918DinmohamedAGVisserOVerhoevenRHALouwmanMWJvan NederveenFHWillemsSMMerkxMAWLemmensVEPPNagtegaalIDSieslingSFewer cancer diagnoses during the COVID-19 epidemic in the NetherlandsThe Lancet Oncology20200621675075110.1016/s1470-2045(20)30265-5Total Expenses and Percent Distribution Selected Conditions by Source of Payment: United States, 2014 (generated interactively)Agency for Healthcare Research and Quality2020-09-01ChowkwanyunMReedALRacial Health Disparities and Covid-19 — Caution and ContextN Engl J Med20200716383320120310.1056/nejmp2012910United Nations Development ProgrammeGender-based violence and COVID-19United Nations20205112020-09-01https://www.undp.org/content/undp/en/home/librarypage/womens-empowerment/gender-based-violence-and-covid-19.htmlBhalaNCurryGMartineauARAgyemangCBhopalRSharpening the global focus on ethnicity and race in the time of COVID-19The Lancet202005395102381673167610.1016/s0140-6736(20)31102-8AldridgeRWLewerDKatikireddiSVMathurRPathakNBurnsRFragaszyEBJohnsonAMDevakumarDAbubakarIHaywardABlack, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality dataWellcome Open Res20205658810.12688/wellcomeopenres.15922.1NardiCSandhuPSelixNCervical Cancer Screening Among Minorities in the United StatesThe Journal for Nurse Practitioners201611121067568210.1016/j.nurpra.2016.08.036Carter-HarrisLSlavenJEMonahanPOShedd-SteeleRHannaNRawlSMUnderstanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokersPrev Med Rep20180610495410.1016/j.pmedr.2018.01.01829552458S2211-3355(18)30018-4PMC5852404TabaacARSutterMEWallCSBakerKEGender Identity Disparities in Cancer Screening BehaviorsAm J Prev Med20180354338539310.1016/j.amepre.2017.11.00929338956S0749-3797(17)30685-2EkeRTariqTLiTIrfanFBColorectal cancer screening in hospitalized patients: results from the Nationwide Inpatient SampleEuropean Journal of Cancer Prevention201928541341910.1097/cej.0000000000000488AkinlotanMBolinJNHelduserJOjinnakaCLichoradAMcClellanDCervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured WomenJ Community Health201708242477077810.1007/s10900-017-0316-92815500510.1007/s10900-017-0316-9PMC5494033SharmaKPDeGroffAScottLShresthaSMelilloSSabatinoSACorrelates of colorectal cancer screening rates in primary care clinics serving low income, medically underserved populationsPrev Med20190912610577410.1016/j.ypmed.2019.10577431319118S0091-7435(19)30250-6PMC6904949EfuniESchofieldEDuhamelKNVillagraCCohenNReidFJandorfLOptimism, Worry, and Colorectal Cancer Screening among Low-income LatinosHealth Behavior and Policy Review2018030152233210.14485/hbpr.5.2.3LiangWGuanWChenRWangWLiJXuKLiCAiQLuWLiangHLiSHeJCancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology20200321333533710.1016/s1470-2045(20)30096-6MandelblattJAndrewsHKaoRWallaceRKernerJThe late-stage diagnosis of colorectal cancer: demographic and socioeconomic factorsAm J Public Health19961286121794710.2105/ajph.86.12.17949003140PMC1380736NegiNJSwanbergJEClouserJMHarmon-DarrowCWorking under conditions of social vulnerability: Depression among Latina/o immigrant horse workersCultur Divers Ethnic Minor Psychol202001261546010.1037/cdp0000276310211472019-22440-001HumphreyJLindstromMBartonKShresthaPCarltonEAdgateJMillerSRootESocial and Environmental Neighborhood Typologies and Lung Function in a Low-Income, Urban PopulationInt J Environ Res Public Health20190329167113310.3390/ijerph1607113330934853ijerph16071133PMC6479348FujishiroKMacDonaldLAHowardVJJob complexity and hazardous working conditions: How do they explain educational gradient in mortality?J Occup Health Psychol20200625317618610.1037/ocp0000171315664012019-58535-001PMC7103547LinJRodriguezSZhouHSparksADSimmensSJAmdurRRacial disparities in late-stage prostate cancer: A SEER database analysis 2005–2015JCO20190301377_suppl11511510.1200/jco.2019.37.7_suppl.115AminiAJonesBYehNGuntupalliSKavanaghBKaramSFisherCDisparities in disease presentation in the four screenable cancers according to health insurance statusPublic Health20160913850610.1016/j.puhe.2016.03.01427091437S0033-3506(16)00105-0YangDXSoulosPRDavisBGrossCPYuJBImpact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific IncidenceAm J Clin Oncol20180341328929410.1097/COC.000000000000026426808257PMC4958036SaumoyMSchneiderYShenNKahalehMSharaihaRZShahSCCost Effectiveness of Gastric Cancer Screening According to Race and EthnicityGastroenterology201809155364866010.1053/j.gastro.2018.05.02629778607S0016-5085(18)34546-3RoeschEAminAGuptaJGarcía-MorenoClaudiaViolence against women during covid-19 pandemic restrictionsBMJ20200507369m171210.1136/bmj.m171232381644PMC7202944Allen-EbrahimianBChina's domestic violence epidemicAxios2020572020-09-01https://www.axios.com/china-domestic-violence-coronavirus-quarantine-7b00c3ba-35bc-4d16-afdd-b76ecfb28882.htmlTaubAA new Covid-19 crisis: Domestic abuse rises worldwideThe New York Times20204142020-09-01https://www.nytimes.com/2020/04/06/world/coronavirus-domestic-violence.htmlPetermanAPottsAO'DonnellMThompsonKShahNOertelt-PrigioneSvan GelderNPandemics and violence against women and children202042020-09-01Washington, DCCenter for Global Developmenthttps://www.researchgate.net/publication/341654631_Pandemics_and_Violence_Against_Women_and_ChildrenWHODepartment of Reproductive Health and Research, London School of Hygiene and Tropical MedicineSouth African Medical Research CouncilGlobal and regional estimates of violence against women: Prevalence and health effects of intimate partner violence and nonpartner sexual violenceWorld Health Organization20132020-09-01https://www.who.int/reproductivehealth/publications/violence/9789241564625/en/Work experience-people 15 years old and over, by total money earnings, age, race, Hispanic origin, sex, and disability statusUnited States Census Bureau20202020-09-01https://www.census.gov/data/tables/time-series/demo/income-poverty/cps-pinc/pinc-05.htmlLevinsonKLJerniganAMFlockeSATergasAIGundersonCCHuhWKWilkinson-RyanILawsonPJFaderANBelinsonJLIntimate partner violence and barriers to cervical cancer screening: A gynecologic oncology fellow research network studyJournal of Lower Genital Tract Disease2016201475110.1097/lgt.0000000000000153MassettiGMTownsendJSThomasCCBasileKCRichardsonLCHealthcare Access and Cancer Screening Among Victims of Intimate Partner ViolenceJ Womens Health (Larchmt)20180527560761410.1089/jwh.2017.640228880705PMC5842092CokerALHopenhaynCDeSimoneCPBushHMCroffordLViolence against Women Raises Risk of Cervical CancerJ Womens Health (Larchmt)20090818811798510.1089/jwh.2008.104819630537AlcaláHéctor EMitchellEKeim-MalpassJAdverse Childhood Experiences and Cervical Cancer ScreeningJ Womens Health (Larchmt)201701261586310.1089/jwh.2016.582327500413Reingle GonzalezJMJetelinaKKOlagueSWondrackJGViolence against women increases cancer diagnoses: Results from a meta-analytic reviewPrev Med20180911416817910.1016/j.ypmed.2018.07.00829981792S0091-7435(18)30215-9GuillaumeELaunayLDejardinOBouvierVGuittetLDéanPaulineNotariADe MilRLaunoyGCould mobile mammography reduce social and geographic inequalities in breast cancer screening participation?Prev Med201707100848810.1016/j.ypmed.2017.04.00628408217S0091-7435(17)30126-3O'DonoghueDSheahanKMacMathunaPStephensRBFenlonHMorrinMMooneyJFahyLEMooneyTSmithAA National Bowel Cancer Screening Programme using FIT: Achievements and ChallengesCancer Prev Res20190205122899410.1158/1940-6207.capr-18-0182LevinTRCorleyDAJensenCDSchottingerJEQuinnVPZauberAGLeeJKZhaoWKUdaltsovaNGhaiNRLeeATQuesenberryCPFiremanBHDoubeniCAEffects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based PopulationGastroenterology201811155513831391.e510.1053/j.gastro.2018.07.01730031768S0016-5085(18)34783-8PMC6240353JessupDLGlover IvMcKinleyDayeDBanziLJonesPChoyGShepardJOFloresEJImplementation of Digital Awareness Strategies to Engage Patients and Providers in a Lung Cancer Screening Program: Retrospective StudyJ Med Internet Res20180215202e5210.2196/jmir.893229449199v20i2e52PMC5832904HartyNMLe GriceKCahillCBullSDwyerAEndCancer: development and pilot testing of multimedia recruitment for a text message campaign to increase cancer screeningMhealth2018104505010.21037/mhealth.2018.10.0230505848mh-04-2018.10.02PMC6232046GuoTFanYChenMWuXZhangLHeTWangHWanJWangXLuZCardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)JAMA Cardiol202007015781181810.1001/jamacardio.2020.1017322193562763845PMC7101506XiaYJinRZhaoJLiWShenHRisk of COVID-19 for patients with cancerThe Lancet Oncology202004214e18010.1016/s1470-2045(20)30150-9ZhangLZhuFXieLWangCWangJChenRJiaPGuanHPengLChenYPengPZhangPChuQShenQWangYXuSZhaoJZhouMClinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnn Oncol20200731789490110.1016/j.annonc.2020.03.29632224151S0923-7534(20)36383-3PMC7270947AhmedFAhmedNPissaridesCStiglitzJWhy inequality could spread COVID-19The Lancet Public Health20200555e24010.1016/s2468-2667(20)30085-2KudererNChoueiriTShahDShyrYRubinsteinSmRiveraDrSheteSHsuCDesaiAde Lima LopesGGrivasPPainterCaPetersSThompsonMaBakounyZBatistGBekaii-SaabTBilenMaBouganimNLarroyaMbCastellanoDDel PreteSaDoroshowDbEganPcElkriefAFarmakiotisDFloraDGalskyMdGloverMjGriffithsEaGulatiApGuptaSHafezNHalfdanarsonTrHawleyJeHsuEKasiAKhakiArLemmonCaLewisCLoganBMastersTMcKayRrMesaRaMorgansAkMulcahyMfPanagiotouOaPeddiPPennellNaReynoldsKRosenLrRosovskyRSalazarMSchmidtAShahSaShayaJaSteinharterJStockerl-GoldsteinKeSubbiahSVinhDcWehbeFhWeissmannLbWuJtWulff-BurchfieldEXieZYehAYuPpZhouAyZubiriLMishraSLymanGhRiniBiWarnerJlAbidiMAcobaJdAgarwalNAhmadSAjmeraAAltmanJAngevineAhAzadNBarMhBardiaABarnholtz-SloanJBarrowBBashirBBelenkayaRBergSBernickerEhBestvinaCBishnoiRBolandGBonnenMBouchardGBowlesDwBusserFCabalACaimiPCarducciTCasuloCChenJlClementJmChismDCookECurranCDaherADaileyMDahiyaSDeekenJDemetriGdDiLulloSDumaNEliasRFallerBFecherLaFeldmanLeFrieseCrFuPFuJFutrealAGainorJGarciaJGillDmGillaspieEaGiordanoAGlace(GGrotheyAGulatiSGurleyMHalmosBHerbstRHershmanDHoskinsKJainRkJabbourSJhaAJohnsonDbJoshiMKelleherKKharofaJKhanHKnobleJKoshkinVsKulkarniAaLammersPeLeightonJcLewisMaLiXLiALoKsLoaiza-BonillaALoRussoPLowCaLustbergMbMahadevanDMansoorAMarcumMMarkhamMjHandy MarshallCMashruShMatarSMcNairCMcWeeneySMehnertJmMenendezAMenonHMessmerMMonahanRMushtaqSNagarajGNagleSNaidooJNakayamaJmNarayanVNelsonHhNemecekErNguyenRNuzzoPvObersteinPeOlszewskiAjOwenbySPasquinelliMmPhilipJPrabhakaranSPucMRamirezARathmannJRevankarSgRhoYsRhodesTdRiceRlRielyGjRiessJRinkCRobilottiEvRosensteinLRoutyBRovitoMaSaifMwSanyalASchapiraLSchwartzCSerranoOShahMShahCShawGShergillAShouseGSoaresHpSolorzanoCcSrivastavaPkStaufferKStoverDgStrattonJStrattonCSubbiahVTamimiRTannirNmTopalogluUVan AllenEVan LoonSVega-LunaKVenepalliNVermaAkVikasPWallSWeinsteinPlWeissMWise-DraperTWoodWaXuW(YackzanSZacksRZhangTZimmerAjWestJClinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyThe Lancet202006395102411907191810.1016/S0140-6736(20)31187-9SirintrapunSJLopezAMTelemedicine in Cancer CareAmerican Society of Clinical Oncology Educational Book2018053854054510.1200/edbk_200141FertlemanCAubugeau-WilliamsPSherCLimALumleySDelacroixSPanXA Discussion of Virtual Reality As a New Tool for Training Healthcare ProfessionalsFront Public Health201822664410.3389/fpubh.2018.0004429535997PMC5834832MetteLSaldívarAnna Maria PulidoPoullardNTorresISethSPollockBTomlinsonGReaching high-risk underserved individuals for cancer genetic counseling by video-teleconferencingJ Community Support Oncol201604144162810.12788/jcso.024727152515StrehleEMShabdeNOne hundred years of telemedicine: does this new technology have a place in paediatrics?Arch Dis Child200612289112956910.1136/adc.2006.0996221711907191/12/956PMC2082971Telemedicine: Opportunities and developments in member statesWorld Health Organization20102020-09-01https://www.who.int/goe/publications/goe_telemedicine_2010.pdfLewisGDHatchSSWiederholdLRSwansonTALong-Term Institutional Experience With Telemedicine Services for Radiation Oncology: A Potential Model for Long-Term UtilizationAdv Radiat Oncol2020075478078210.1016/j.adro.2020.04.01832391444S2452-1094(20)30094-4PMC7205717OchsMMestreDde MontcheuilGPergandiJSaubestyJLombardoEFranconDBlachePTraining doctors’ social skills to break bad news: evaluation of the impact of virtual environment displays on the sense of presenceJ Multimodal User Interfaces201914131415110.1007/s12193-018-0289-8LopezAMAlbertsDSHessLMTelemedicine, telehealth, and e-Health technologies in cancer preventionFundamentals of Cancer Prevention2019ChamSpringer International Publishing333352MenduSBoukhechbaMGordonJDattaDebajyotiMolinaEdwinArroyoGloriaProctorSara KWellsKristen JBarnesLaura EDesign of a Culturally-Informed Virtual Human for Educating Hispanic Women about Cervical CancerProceedings of the 12th EAI International Conference on Pervasive Computing Technologies for Healthcare201805201836036610.1145/3240925.324096830555731PMC6292436LiangBYangNHeGHuangPYangYIdentification of the Facial Features of Patients With Cancer: A Deep Learning-Based Pilot StudyJ Med Internet Res20200429224e1723410.2196/1723432347802v22i4e17234PMC7221634The rise of the data-driven physicianStanford University20202020-10-16https://med.stanford.edu/content/dam/sm/school/documents/Health-Trends-Report/Stanford%20Medicine%20Health%20Trends%20Report%202020.pdfLeeAMoyLKruckSERabangJThe doctor is in, but is academia? Re-tooling IT education for a new era in healthcareJournal of Information Systems Education2014254275282CarrollNRichardsonIMoloneyMO’ReillyPBridging healthcare education and technology solution development through experiential innovationHealth Technol20171178425526110.1007/s12553-017-0209-zBotrugnoCInformation technologies in healthcare: Enhancing or dehumanising doctor-patient interaction?Health (London)20191218136345931989121310.1177/136345931989121331849239BidgoliHSuccessful Integration of Information Technology in Healthcare: Guides for ManagersJSIS201891133e10.33423/jsis.v13i3.615Mobile fact sheetPew Research Center20196122020-09-01https://www.pewresearch.org/internet/fact-sheet/mobile/mHealth Economics 2017/2018 – Connectivity in Digital HealthResearch 2 Guidance20182020-09-01https://research2guidance.com/product/connectivity-in-digital-health/GordonWJLandmanAZhangHBatesDWBeyond validation: getting health apps into clinical practiceNPJ Digit Med202023311410.1038/s41746-019-0212-z32047860212PMC6997363NoarSMHarringtonNGAldrichRSThe Role of Message Tailoring in the Development of Persuasive Health Communication MessagesAnnals of the International Communication Association201605183317313310.1080/23808985.2009.11679085WakefieldMALokenBHornikRCUse of mass media campaigns to change health behaviourThe Lancet20101037697481261127110.1016/s0140-6736(10)60809-4KeyTMCzaplewskiAJUpstream social marketing strategy: An integrated marketing communications approachBusiness Horizons20170560332533310.1016/j.bushor.2017.01.006PattiCHartleySvan DesselMBaackDImproving integrated marketing communications practices: A comparison of objectives and resultsJournal of Marketing Communications2015042323435137010.1080/13527266.2015.1027251MerrillRMTelfordCTPharmaceutical use according to participation in worksite wellness screening and health campaignsPrev Med Rep2018121215816310.1016/j.pmedr.2018.09.00830263886S2211-3355(18)30191-8PMC6156915SpringerSMMcFallAHagerPPercy-LauryAVinsonCALung cancer screening: an emerging cancer control issue presents opportunities for an awareness campaign in rural MichiganCancer Causes Control2018121829121257126310.1007/s10552-018-1080-63022940110.1007/s10552-018-1080-6ShaukatAChurchTColorectal cancer screening in the USA in the wake of COVID-192020085872672710.1016/s2468-1253(20)30191-6NodoraJGuptaSHowardNMotadelKellyPropstTobeRodriguezJavierSchultzJamesVelasquezSharonCastañedaSheila FRabinBorsikaMartínezMaría ElenaThe COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved CommunitiesJ Natl Cancer Inst20200811202010.1093/jnci/djaa117327808515891177PMC7454700Del Vecchio BlancoGCalabreseEBianconeLMonteleoneGPaoluziOAThe impact of COVID-19 pandemic in the colorectal cancer preventionInt J Colorectal Dis2020100435101951195410.1007/s00384-020-03635-63250043210.1007/s00384-020-03635-6PMC7271141